Valuation Unicycive Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 01:30:00 23/09/2026 am IST			5-day change	1st Jan Change
4.960 ^USD	+3.98%		+5.31%	-14.04%

13/08	B. Riley Adjusts Price Target on Unicycive Therapeutics to $20 From $22, Maintains Buy Rating	MT
12/08	Unicycive Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	30.84	8.148	30.16	82.44	124	138.2	-	-
Change	-	-73.58%	270.11%	173.36%	50.43%	11.42%	-	-
Enterprise Value (EV)	30.84	8.148	30.16	82.44	124	138.2	138.2	138.2
Change	-	-73.58%	270.11%	173.36%	50.43%	11.42%	0%	0%
P/E	-2.4x	-0.45x	-0.68x	-1.42x	-3.46x	-4.04x	2.74x	0.59x
PBR	-	-	-	-	-	-	-	-
PEG	-	-0x	-0.1x	0x	0x	0.2x	-0x	0x
Capitalization / Revenue	-	8.57x	44.7x	-	-	377x	0.92x	0.25x
EV / Revenue	-	0x	0x	-	-	377x	0.92x	0.25x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-3.62x	2.36x	0.37x
EV / FCF	-0x	-	-0x	-0x	-0x	-4.24x	-6.67x	0.91x
FCF Yield	-18.8%	-	-60.7%	-34.8%	-25.3%	-23.6%	-15%	110%
Dividend per Share ²	-	-	-	-	-	-	2.08	5.37
Rate of return	-	-	-	-	-	-	41.9%	108%
EPS ²	-8.6	-12	-12.8	-5.6	-1.67	-1.229	1.813	8.45
Distribution rate	-	-	-	-	-	-	115%	63.6%
Net sales ¹	-	0.951	0.675	-	-	0.3667	150.2	548.1
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-8.977	-18.05	-20.77	-32.12	-29.52	-38.17	58.62	369.9
Net income ¹	-10.02	-18.06	-31.41	-37.82	-26.56	-34.62	56.21	349.6
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	20.600	5.400	8.677	7.942	5.770	4.960	4.960	4.960
Nbr of stocks (in thousands)	1,497	1,509	3,475	10,380	21,491	27,855	-	-
Announcement Date	31/03/22	31/03/23	28/03/24	31/03/25	30/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
UNICYCIVE THERAPEUTICS, INC.	-4.04x	-	-	-	14Cr
WUXI APPTEC CO., LTD.	21.8x	7.74x	15.55x	1.36%	7.43TCr
ARGENX SE	31.81x	9.18x	28.6x	0.04%	6.12TCr
WUXI BIOLOGICS (CAYMAN) INC.	31.83x	6.79x	17.62x	-.--%	2.75TCr
INSMED INCORPORATED	-73.75x	14.26x	-68.76x	-.--%	2.64TCr
BIONTECH SE	-15.46x	5.96x	-7.5x	-.--%	2.53TCr
GENMAB A/S	28.48x	5.36x	17.82x	-.--%	2.08TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1066.25x	37.33x	644.76x	-.--%	1.49TCr
PHARMAESSENTIA CORPORATION	43.75x	16.03x	32.53x	0.34%	1.52TCr
EXELIXIS, INC.	17.96x	5.35x	12.5x	-.--%	1.44TCr
Average	114.86x	12.00x	77.01x	0.19%	2.8TCr
Weighted average by Cap.	69.75x	10.14x	43.06x	0.39%